# Translational Pathology

> **NIH NIH P30** · THOMAS JEFFERSON UNIVERSITY · 2022 · $343,208

## Abstract

TPSR Summary 
The mission of the Sidney Kimmel Cancer Center Translational Pathology Shared Resource (TPSR) is to 
serve as a biomedical research resource supporting novel cancer research for the SKCC's basic, clinical, and 
translational members. The TPSR provides immediate, single-portal access to pathology and informatics 
faculty expertise and technical support, including a comprehensive range of high-quality pathology and 
informatics services coupled with critical access to unique banked tissue collections. The TPSR was founded 
in 2000 and has been continuously funded by the NCI since 2001. The former Informatics Shared Resource 
(ISR) was integrated into the TPSR during the current project period, due to the close working relationship and 
mutual focus of informatics with pathology services. Stephen Peiper, MD, oversees the combined Shared 
Resource. Wei Jiang, MD, PhD, and Haifeng Yang, PhD, serve as Pathology Co-Directors under the direction 
of Dr. Peiper. Zhijiu Zhong, MD, MS, is an experienced facility manager responsible for the day-to-day 
operation of the TPSR. The TPSR has dedicated laboratory space in the centrally located Bluemle Life 
Sciences Building (BLSB). In addition, there is connecting office space for consultation on histology and 
informatics needs. Current TPSR goals include: 1) Provide data, specimens, and technology to enhance all 
aspects of oncology research; 2) Offer a full range of exceptional histopathology services: IHC (including multi- 
parameter), ISH, automation, laser capture microdissection, tissue array creation, and digital pathology with 
high res image analysis; 3) Give access to a CAP-accredited biorepository; 4) Provide biomedical research 
informatics tools for facile interrogation of a well-developed data warehouse.

## Key facts

- **NIH application ID:** 10447609
- **Project number:** 5P30CA056036-23
- **Recipient organization:** THOMAS JEFFERSON UNIVERSITY
- **Principal Investigator:** Wei Jiang
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $343,208
- **Award type:** 5
- **Project period:** 1995-06-22 → 2024-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10447609

## Citation

> US National Institutes of Health, RePORTER application 10447609, Translational Pathology (5P30CA056036-23). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10447609. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*